Type of criteria Criterion Imaging Major Active inflammation CE-MRI, USPIO-MRI, FDG-PET Thin FC with large LRNC MRI, CE-MRI, CT FC disruption MRI, CE-MRI, SPECT Severe stenosis MRA, CTA, B-mode ultrasonography…
Plaque characteristic MRI CT US PET SPECT DSA Active inflammation ✓ x x ✓ x x Thin FC with large LRNC ✓ ✓ x x x x FC disruption ✓…
10-s acquisition 20-s acquisition Low dose High dose High dose Rotation times (s) 10 10 20 Rotation angle (°) 219 219 219 Increment 0.8 0.8 0.4 No. of frames…
Fig. 44.1 Left subclavear adenopathy measuring less than a centimeter In the left para-aortic and celiac-mesenteric areas and hepatic hilum, there are numerous confluent enlarged lymph nodes, characterized by high glucose…
Fig. 78.1 The PET shows progression of disease due to the presence of a lung metastasis and lymph nodes characterized by increased deposition of FDG Fig. 78.2 The CT shows a solid…
Fig. 62.1 The MIP image shows metabolic response of the left lung mass but there is a clear progression of disease in all mediastinal and abdominal injuries. Moreover, we find the…
Fig. 76.1 The PET scan shows multiple enlarged lymph nodes with high glucose metabolism in the celiac-mesenteric-aortic, left lumbo-aortic regions; bilaterally in the iliac region, even though more pronounced on the…
Fig. 18.1 PET scan before chemotherapy Absence of pathological metabolism in other body segments examined. 18.4 Conclusions The PET scan shows partial response to treatment, due to persistence of mild metabolic…
Fig. 23.1 Presence of some lymph nodes in the left para-aortic region that compress the pyeloureteral junction without causing obstruction (MIP image) 23.4 Conclusions The PET scan shows extended locoregional recurrence…
Fig. 73.1 PET scan showed abnormal glucose consumption of the right lung hilar nodule Softer carbohydrate consumption of the right posterolateral tenth rib, SUV max 2.8. No areas of abnormal metabolism…
